Publications

03 Mar 2009
First Look

First Look: March 3, 2009

control over pricing and associated revenues from the content to the content provider in order to reduce price competition at the platform level.... View Details

Keywords: Martha Lagace

May 2009 (Revised October 2009)
Case

Newton-Wellesley Hospital

By: Richard M.J. Bohmer and Natalie Kindred

How will Newton-Wellesley Hospital (NWH) preserve its private practice tradition while remaining effective and competitive in a healthcare industry demanding increasing integration between physicians and hospitals? This is the decision facing Newton-Wellesley Hospital... View Details

Keywords: Business Model; Profit; Health Care and Treatment; Growth and Development Strategy; Organizational Change and Adaptation; Organizational Structure; Competitive Strategy; Integration; Health Industry; Massachusetts

17 Feb 2015
News

The First Five Years: Diogo Castro Freire (MBA 2012)

it means for them. It is particularly hard in the U.S. because the topic has become unnecessarily controversial and polarizing. This is a massive... View Details

Keywords: Arts, Entertainment; Motion Picture and Sound Recording Industries; Information

01 Apr 2002
News

Urban Evolution - HBS Research on the Inner City

of the inner city (lack of health care and substandard housing, for example) are important, they do not get at all the root causes. "To build healthy and sustainable inner-city... View Details

Keywords: Paul Grogan; Peter Tufano; David Crockett; Diana Barrett; Real Estate

01 Feb 2000
News

The Future Is Now: 21st-Century Business Pondered at HBS Forum

remarks, Porter noted two potential threats to America in its current role as the standard bearer of global commerce: U.S. capital markets could get too near-term oriented, and... View Details

22 May 2020
In Practice

Post-COVID Health Care: More Screens, Less Red Tape?

The coronavirus crisis forced health care providers to mobilize in ways few could have predicted six months ago, revealing not only the system’s... View Details

Keywords: by Danielle Kost

30 Mar 2010
First Look

First Look: March 30

Peter Tufano Abstract We use a unique, nationally representative cross-national dataset to document the reduction in individuals' usage of routine non-emergency medical care... View Details

Keywords: Sean Silverthorne

January 2023
Case

Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery

By: Regina Herzlinger and Brian Walker

What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details

Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry

02 May 2017
First Look

First Look at New Research: May 2, 2017

showing a passenger being dragged from a plane. Of all the U.S. air carriers, United should have known the power of social media and public outrage. It had learned years... View Details

Keywords: Carmen Nobel

May 2023 (Revised June 2023)
Case

Novartis (A): Reimagining Medicine

By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi

This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details

Keywords: Health Care and Treatment; Business Model; Leadership; Pharmaceutical Industry; Switzerland

23 Jan 2008
First Look

First Look: January 23, 2008

donations. To assess their potential impact, an archival survey of voluntary, in-state whole-body donors to two programs procuring in the same U.S. state was conducted. View Details

Keywords: Martha Lagace

2024
Working Paper

Gastrointestinal Endoscopy--Without Cutting In: Case Histories of Transformational Advances

By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins

This case history describes how endoscopy transformed the diagnosis of ulcers, cancerous polyps, and other alimentary canal diseases and enabled “minimally invasive” surgeries to treat such diseases. Specifically, we chronicle how: 1) flexible glass fiber endoscopes... View Details

Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms

SSRN

Read Now

May 2023 (Revised June 2023)
Supplement

Novartis (C): Reimagining Medicine

By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi

This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details

Keywords: Health Testing and Trials; Health Care and Treatment; Business Model; Problems and Challenges; Pharmaceutical Industry; Switzerland

September 2012 (Revised August 2015)
Case

Shanghai Pharmaceuticals

By: Regina E. Herzlinger and Natalie Kindred

Shanghai Pharmaceuticals (SPH), a vertically integrated Chinese pharmaceutical conglomerate, was considering its strategic options in the context of a rapidly evolving industry, policy, and economic environment. The company—essentially a collection of subsidiaries... View Details

Keywords: Business Subsidiaries; Business Conglomerates; Vertical Integration; Decision Choices and Conditions; Mergers and Acquisitions; Consolidation; Health Care and Treatment; Global Strategy; State Ownership; Pharmaceutical Industry; Health Industry; Shanghai; United States; Europe

20 Nov 2018
First Look

New Research and Ideas, November 20, 2018

Abstract—In a survey of the NEJM Catalyst Insights Council in July 2018, 42% of respondents say they think value-based reimbursement models will be the primary revenue model... View Details

Keywords: Dina Gerdeman

28 Feb 2013
News

Q&A: Charlie Rose Talks to Harvard's Michael Porter

Research Summary

Health-care Applications

Active postmarketing drug surveillance. There is substantial interest within the U.S. health community and among health policymakers in developing a surveillance system that scans public health databases in order to proactively detect potential drug safety... View Details

May 2023 (Revised June 2023)
Supplement

Novartis (B): Reimagining Medicine

By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi

This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details

Keywords: Health Care and Treatment; Business Model; Production; Business Strategy; Pharmaceutical Industry